Aetna Unveils 2027 Medicare Plans Focused on Cost and Access
Aetna's 2027 Medicare offerings emphasize zero-dollar copays on key drugs, preventive care, and in-home health visits for members.
Aetna has announced its 2027 Medicare plan lineup, highlighting benefits designed to reduce out-of-pocket costs and broaden access to routine and preventive care for enrolled members. The plans are structured around eliminating copays at the point of care for a range of common services and medications.
Under the new offerings, members face no copay for Tier 1 prescription drugs and covered vaccines when using in-network pharmacies. The same zero-cost structure applies to core preventive screenings — including annual physicals, colonoscopies, and mammograms — when obtained through in-network providers.
Read more Aetna Unveils 2027 Medicare Plans Focused on Low-Cost Care →
A notable feature of the 2027 plans is the inclusion of annual Healthy Home Visits conducted by licensed clinicians through Signify Health, a provider specializing in in-home health evaluations. These visits, also covered at no copay, are intended to help identify health risks and connect members with appropriate follow-up care without requiring a separate office visit.
The benefit design reflects a broader industry trend among Medicare Advantage insurers to compete on value-added services and cost transparency, particularly as regulators and consumers scrutinize plan affordability. Aetna's approach targets enrollees who rely on predictable, low-cost access to both prescription medications and preventive screenings as a foundation for managing chronic or emerging health conditions.
Continue reading at All Financial Services & Investing.
